Table 4.
Correlations Between Attentional ERP Components and Clinical Characteristics in aCSVD Patients
| Original/Difference ERPs | MMSE | MoCA | Fazekas | PHQ-9 | GAD-7 |
|---|---|---|---|---|---|
| r (p value) | r (p value) | r (p value) | r (p value) | r (p value) | |
| P3 amplitude-standard | −0.225 (0.052) | −0.115 (0.328) | −0.154 (0.186) | 0.178 (0.126) | −0.214 (0.065) |
| P3 amplitude-target (p3b) | −0.054 (0.643) | −0.059 (0.614) | −0.321 (0.005)* | −0.071 (0.544) | −0.151 (0.197) |
| P3 amplitude-novel (p3a) | 0.034 (0.771) | 0.125 (0.284) | −0.377 (0.001)* | 0.011 (0.927) | 0.069 (0.556) |
| P3 latency-standard | −0.099 (0.398) | −0.078 (0.505) | 0.107 (0.363) | −0.042 (0.723) | −0.132 (0.259) |
| P3 latency-target (p3b) | 0.042 (0.719) | −0.025 (0.828) | −0.192 (0.100) | −0.042 (0.719) | 0.107 (0.361) |
| P3 latency-novel (p3a) | −0.133 (0.256) | −0.127 (0.277) | 0.338 (0.003)* | −0.093 (0.426) | 0.100 (0.393) |
| P3dT amplitude | 0.018 (0.878) | −0.057 (0.625) | 0.005 (0.963) | −0.085 (0.470) | 0.094 (0.422) |
| P3dN amplitude | 0.033 (0.779) | −0.161 (0.168) | −0.193 (0.097) | 0.152 (0.194) | 0.116 (0.320) |
| P3dT latency | −0.195 (0.093) | 0.063 (0.589) | 0.152 (0.193) | −0.194 (0.096) | 0.138 (0.238) |
| P3dN latency | −0.001 (0.994) | 0.031 (0.789) | 0.053 (0.652) | −0.109 (0.354) | 0.104 (0.374) |
Notes: P3dT: target minus standard, P3dN: novel minus standard; *P < 0.05.